Ultralife (ULBI) Gains from Investment Securities (2010 - 2026)

Ultralife's Gains from Investment Securities history runs 17 years deep, the most recent figure standing at $963482.0 for Q1 2026.

• In Q1 2026, Gains from Investment Securities changed N/A year-over-year to $963482.0; the TTM figure through Mar 2026 stood at $963482.0 (changed N/A YoY), while the FY2025 annual figure was $967351.0, down 12.57% from the prior year.
• Gains from Investment Securities was $963482.0 for Q1 2026 at Ultralife, roughly flat from $967351.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.4 million in Q1 2023 to a low of $3460.0 in Q3 2024.
• Historically, Gains from Investment Securities has averaged $585133.3 across 5 years, with a median of $554086.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities plunged 97.61% in 2024, then soared 28428.82% in 2025.
• A 5-year view of Gains from Investment Securities shows it stood at $77000.0 in 2022, then sank by 89.61% to $8000.0 in 2023, then surged by 13730.45% to $1.1 million in 2024, then fell by 12.57% to $967351.0 in 2025, then declined by 0.4% to $963482.0 in 2026.
• The last three Gains from Investment Securities figures came in at $963482.0 (Q1 2026), $967351.0 (Q4 2025), and $987097.0 (Q3 2025), per Business Quant data.